Glenmark gets USFDA nod for pneumonia treatment drug

New Delhi: Glenmark Pharmaceuticals Thursday said it has received final approval from the US health regulator for Atovaquone, used for prevention and treatment of a type of pneumonia. Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food and Drug Administration (USFDA) for Atovaquone Oral Suspension USP in the strength of 750 mg/5 mL,” the company said in a BSE filing.

The approved drug is a generic version of GlaxoSmithKline’s Mepron Oral Suspension of similar strength.

Quoting IQVIA sales data, Glenmark said, Mepron Oral Suspension market achieved annual sales of approximately USD 119.1 million.

The company’s current portfolio consists of 144 products authorised for distribution in the US marketplace and 55 abbreviated new drug applications (ANDAs) pending approval with the USFDA.

The company’s shares were trading at Rs 633.10 apiece, down 1.26 per cent, on the BSE.

  • Related Posts

    • Pharma
    • October 17, 2024
    • 115 views
    CSIR-NIIST To Establish Centres Of Excellence In Ayurveda, Performance Chemicals

    Thiruvananthapuram:  The Centre of Excellence in Ayurveda Research to be established on the campus of the CSIR-National Institute for Interdisciplinary Science and Technology (NIIST) at Pappanamcode here is envisaged as…

    • Pharma
    • October 17, 2024
    • 99 views
    India, Uzbekistan Discuss Ways To Ensure Quality, Safety In Pharma Sector

    New Delhi:  A delegation from Uzbekistan met officials from India’s Central Drugs Standard Control Organisation and discussed areas of collaboration, including the development of a pharmacovigilance system and reducing adverse…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    CSIR-NIIST To Establish Centres Of Excellence In Ayurveda, Performance Chemicals

    CSIR-NIIST To Establish Centres Of Excellence In Ayurveda, Performance Chemicals

    India, Uzbekistan Discuss Ways To Ensure Quality, Safety In Pharma Sector

    India, Uzbekistan Discuss Ways To Ensure Quality, Safety In Pharma Sector

    Health Worker Arrested For Mixing TB Patient’s Sputum In Doctor’s Food

    Health Worker Arrested For Mixing TB Patient’s Sputum In Doctor’s Food

    Cipla, Alkem Eye Rs 4,000 Crore Stake In India’s Largest Stent Manufacturer

    Cipla, Alkem Eye Rs 4,000 Crore Stake In India’s Largest Stent Manufacturer

    DTAB Recommends To Do Away With Toxicity Studies For Intravenous Infusions And Injectables

    DTAB Recommends To Do Away With Toxicity Studies For Intravenous Infusions And Injectables

    Delhi-Gujarat Haul: Drugs Brought From S America, Purified In Ankleshwar

    Delhi-Gujarat Haul: Drugs Brought From S America, Purified In Ankleshwar